Weight
Semaglutide
Metabolic
31
Amino acids
Molecular weight
Peptide
Type
Long-acting GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management. Over 17,000 trial participants have demonstrated significant efficacy through appetite suppression and glycemic control. The 7-day half-life enables convenient weekly dosing.
Top researched benefits
Overview of Semaglutide
Mimics native GLP-1, binding to receptors to stimulate glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite via hypothalamic pathways.
Weight Loss
- FDA-approved for chronic weight management with average 15-20% body weight loss in clinical trials.
- Reduces hunger and food cravings through central nervous system GLP-1 receptor activation.
- Long-term studies show maintained weight loss with continued treatment over 2+ years.
Diabetes
- FDA-approved for type 2 diabetes with HbA1c reductions of 1.5-2% in clinical trials.
- Proven 26% reduction in cardiovascular death, MI, or stroke in high-risk diabetes patients.
- Improves insulin secretion and may preserve pancreatic beta cell function.
Metabolic
- Addresses multiple components: weight, glucose, blood pressure, and lipids.
- Emerging evidence for improvements in non-alcoholic fatty liver disease.
- Decreases systemic inflammation markers independent of weight loss.
Storage
Pen: 2-8°C before first use, room temp up to 56 days after. Compounded: 2-8°C
Frequency
Once weekly (same day each week)
Typical Dose
0.25mg starting, titrate to 1-2.4mg weekly
Cycle Duration
Ongoing therapy as prescribed
Chemical Makeup
Key benefits
15-20% average body weight reduction
Established cardiovascular protection
Convenient once-weekly dosing options
Comprehensive safety data from extensive trials
Flexible injectable and oral formulations
Community interest
This peptide is still gaining traction in the community.
GLP-1 Receptor Agonist | Weight Loss & Diabetes
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesSemaglutide Molecular Information
View the scientifc details of Semaglutide.
31
Amino Acids
Semaglutide
His
His
Position 1
Sec
Sec
Position 2
Glu
Glu
Position 3
Gly
Gly
Position 4
Thr
Thr
Position 5
Phe
Phe
Position 6
Thr
Thr
Position 7
Ser
Ser
Position 8
Asp
Asp
Position 9
Val
Val
Position 10
Ser
Ser
Position 11
Ser
Ser
Position 12
Tyr
Tyr
Position 13
Leu
Leu
Position 14
Glu
Glu
Position 15
Gly
Gly
Position 16
Gln
Gln
Position 17
Ala
Ala
Position 18
Ala
Ala
Position 19
Lys
Lys
Position 20
Glu
Glu
Position 21
Phe
Phe
Position 22
Ile
Ile
Position 23
Ala
Ala
Position 24
Trp
Trp
Position 25
Leu
Leu
Position 26
Val
Val
Position 27
Arg
Arg
Position 28
Gly
Gly
Position 29
Arg
Arg
Position 30
Gly
Gly
Position 31
Molecular Weight
4DaChain Length
31Amino AcidsType
PeptideSemaglutide Protocols
Pre-filled pen devices for once-weekly subcutaneous injection. Brands include Ozempic (diabetes) and Wegovy (weight loss).
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| Weight Loss Initiation | 0.25 | 4 week range | Subcutaneous |
| Weight Loss Maintenance | 2.4 | 16 week range | Subcutaneous |
| Diabetes Management | 0.5 | — | Subcutaneous |
| Cardiovascular Protection | 0.5 | — | Subcutaneous |
| Tolerability-Based | 0.25 | — | Subcutaneous |
Reconstitution Instructions
Materials needed:
Steps to reconstitute
- If using pre-filled pen, attach new needle and prime per instructions
- If using vial, draw prescribed dose with appropriate syringe
- Clean injection site with alcohol swab and let dry
- Inject subcutaneously at 90-degree angle (45-degree if lean)
- Hold for 6 seconds after injection to ensure full dose delivery
- Dispose of needle safely and rotate injection sites weekly
Semaglutide Cycle
The Semaglutide Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
- Week 1-4
- Mild appetite reduction, possible nausea during initial dose
- Month 2-3
- Noticeable weight loss (5-10% typical), improved satiety
- Month 4-6
- Continued weight loss (10-15% common), stable glucose levels
- Week 0-0
- Weight loss plateau possible, focus on maintenance
- Week 0-0
- Blood sugar improvements within 1-2 weeks
Dosing tools
Semaglutide Peptide Dosage Calculator
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
5 units
0.050 mL
1 mL
2 mL
3 mL
5 mL
Custom
Conversion: 1,000 mcg = 1 mg
Injection Results
Based on your vial and dilution inputs.
Safe concentration range
Semaglutide
SINGLE COMPOUNDVolume per injection
0.05
mL
Concentration
10.00
mg/mL
Doses per vial
20
doses
Total injections per vial
20 injections
How it works
Based on a 10 mg Semaglutide vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Reference Guide
Dosing Cycle
- Peptide
- Semaglutide
- Dosing
- 0.25mg starting, titrate to 1-2.4mg weekly
- Dosing Frequency
- Once weekly (same day each week)
- Cycle Duration
- Ongoing therapy as prescribed
- Storage
- Pen: 2-8°C before first use, room temp up to 56 days after. Compounded: 2-8°C
Note: Triple agonist; microdose for fewer side effects
Reconstitution Tips
- Use bacteriostatic water (BAC) — contains 0.9% benzyl alcohol for preservation
- Inject water slowly — aim down the vial wall, not directly onto powder
- Never shake — gently swirl or roll the vial until dissolved
- Store properly — refrigerate at 2-8°C after reconstitution
- Use within 28 days — most reconstituted peptides remain stable for about 4 weeks
- Keep sterile — always clean vial tops with alcohol before drawing
Peptide Interactions
Research suggestions of Semaglutide interactions with other common peptides and substances.
Weight
cag
Metabolic
Cagrilintide
SYNERGISTIC
Combined as CagriSema in clinical trials for enhanced weight loss efficacy.
Weight
tir
Metabolic
Tirzepatide
AVOID
Both are incretin mimetics with overlapping mechanisms; concurrent use increases side effects.
Side effects
Avoid: Do not take Semaglutide with Tirzepatide.
Contraindications
Personal or family history of medullary thyroid cancer
Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Pregnancy or breastfeeding
History of pancreatitis
Stop signs
Severe persistent abdominal pain (possible pancreatitis)
Persistent vomiting preventing fluid intake
Signs of thyroid tumor (neck lump, hoarseness, trouble swallowing)
Severe allergic reaction (rash, itching, difficulty breathing)
Vision changes (possible diabetic retinopathy progression)
Severe hypoglycemia (if combined with insulin/sulfonylureas)
Kidney problems (decreased urination, swelling)
Bad signs
Comments
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Frequently asked questions
What benefits can peptides offer in research?
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
What are some exciting applications of peptides in modern science?
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
How do peptides influence health and wellness?
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Where can I find the latest studies on peptide applications?
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Are there any guidelines for using peptides in research?
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
What is the difference between peptides and proteins?
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
How should peptides be stored?
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Can peptides be taken orally?
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
SemaglutideResearch References
Semaglutide is a fda approved compound
Semaglutide
Semaglutide is a fda approved compound
STEP 1 Trial - Weight Management
14.9% average weight loss versus 2.4% with placebo over 68 weeks with 2.4mg weekly.
2021
SELECT Cardiovascular Outcomes
20% reduction in major adverse cardiovascular events over 5 years with 2.4mg weekly.
2023
SUSTAIN Diabetes Program
Average HbA1c reductions of 1.5-1.8% across multiple trials.
2016
STEP 5 Two-Year Maintenance
Sustained weight loss of 15.2% at week 104 with 2.4mg weekly.
2022
PIONEER Oral Semaglutide
Oral efficacy comparable to injectable formulations at 3-14mg daily.
2019
STEP TEENS Adolescent Study
16.1% BMI reduction in adolescent population over 68 weeks.
2022